Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
NHS
18,612 stories
FDA
4,376 stories
Salon
1,594 stories
NHS England
1,145 stories
NICE
1,003 stories
Eli Lilly
605 stories
CMS
292 stories
UCL
288 stories
Lilly
275 stories
Biogen
270 stories
KFF
234 stories
Alzheimer Society
206 stories
the Food and Drug Administration
107 stories
Eisai
95 stories
Alzheimer Research UK
94 stories
Biogen Inc
79 stories
Eli Lilly and Company
46 stories
the Alzheimer Association
29 stories
JAMA
28 stories
Leqembi
24 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics